Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: An analysis of DPV and DIVE registry patients with chronic kidney disease according to the finerenone phase III clinical trial selection criteria

Fig. 2

Patients’ CKD characteristics: comparison of DPV/DIVE population (n = 65,168) with FIDELITY clinical trial populations. The figure describes the proportion of patients in the FIDELITY and the DIVE/DPV analysis respectively by subgroups defined by albuminuria and eGFR. eFGR, estimated glomerular filtration rate

Back to article page